- Home
- VITL vs CLPT Comparison
VITL vs CLPT Comparison
Compare VITL & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VITL | CLPT |
|---|---|---|
| Founded | 2007 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 479.5M | 554.2M |
| IPO Year | 2020 | 2009 |
Fundamental Metrics
Financial Performance| Metric | VITL | CLPT |
|---|---|---|
| Price | $12.71 | $18.72 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 1 |
| Target Price | ★ $32.00 | $20.00 |
| AVG Volume (30 Days) | ★ 2.5M | 892.4K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.03 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $759,444,000.00 | $36,971,000.00 |
| Revenue This Year | $19.72 | $45.67 |
| Revenue Next Year | $17.02 | $19.51 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 25.26 | 17.78 |
| 52 Week Low | $7.95 | $8.27 |
| 52 Week High | $53.13 | $30.10 |
Technical Indicators
Market Signals| Indicator | VITL | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 68.89 | 66.53 |
| Support Level | $12.09 | $12.55 |
| Resistance Level | $13.47 | $27.64 |
| Average True Range (ATR) | 0.66 | 1.47 |
| MACD | 0.25 | 0.17 |
| Stochastic Oscillator | 89.84 | 86.13 |
Price Performance
Historical ComparisonAbout VITL Vital Farms Inc.
Vital Farms Inc is an ethical food company. The company retails pasture-raised eggs and butter. Its products include Pasture-Raised Eggs and Pasture-Raised Butter & Ghee. The company's purpose is rooted in a commitment to Conscious Capitalism, which prioritizes the long-term benefits of its stakeholders (farmers and suppliers, customers and consumers, communities and the environment, employees, and stockholders).
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.